Alert: New Earnings Report (8/7/24)-EyePoint Pharmaceuticals Inc (NASDAQ: EYPT).
For its second fiscal quarter (ending June 30), EyePoint Pharmaceuticals Inc (NASDAQ: EYPT) has reported E.P.S. of $-0.58 compared to $-0.61 a year ago. This result fell short of the consensus estimate of $-0.53 by […]